Loading clinical trials...

UNKNOWNPhase 2/3NCT02440152

The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention

The nucleus accumbens (NAcc) has a significant role in the process of opiate addiction and the initiation of relapse after detoxification. There is evidence that deep brain stimulation (DBS) of the NA...

Lead sponsor: Ruijin Hospital•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

ChenCheng Zhang, MD

CONTACT

i@cczhang.org

Kristina Zeljic, MSc

CONTACT

zeljickristina@ion.ac.cn

Related studies

COMPLETEDNA

On-site Evaluation of Substances Consumption on Opiate Maintenance

NCT02345655 · Opiate Addiction

COMPLETEDPhase 3

Long-acting Naltrexone for Pre-release Prisoners

NCT02867124 · Opiate Addiction

TERMINATEDPhase 2

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

NCT03831113 · Opiate Addiction, Pregnancy

COMPLETEDPhase 4

Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia

NCT02396979 · Human Immunodeficiency Virus, Acquired Immunodeficiency Syndrome, and more

COMPLETEDNA

Study of Treatment for Opioid Dependence and Anxiety Disorders

NCT02252068 · Anxiety Disorders, Opiate Addiction

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 29, 2017Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE2/PHASE3

Enrollment6

Start dateFeb 2017

Last updatedJun 29, 2017

Condition

Opiate Addiction

Locations shown

Shanghai RuiJin Hospital Psychitric Department

Shanghai, Shanghai Municipality

Shanghai Mental Health Center

Shanghai, Shanghai Municipality

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 29, 2017Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions